Vaňhara P - Search Results

1

Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.

Kratochvílová K, Horak P, Ešner M, Souček K, Pils D, Anees M, Tomasich E, Dráfi F, Jurtíková V, Hampl A, Krainer M, Vaňhara P. Kratochvílová K, et al. Among authors: vanhara p. Int J Cancer. 2015 Sep 15;137(6):1330-40. doi: 10.1002/ijc.29502. Epub 2015 Mar 21. Int J Cancer. 2015. PMID: 25735931 Free article.

2

c-Jun induces apoptosis of starved BM2 monoblasts by activating cyclin A-CDK2.

Vanhara P, Bryja V, Horváth V, Kozubík A, Hampl A, Smarda J. Vanhara P, et al. Biochem Biophys Res Commun. 2007 Feb 2;353(1):92-7. doi: 10.1016/j.bbrc.2006.11.124. Epub 2006 Dec 4. Biochem Biophys Res Commun. 2007. PMID: 17173865

3

Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.

Vanhara P, Lincová E, Kozubík A, Jurdic P, Soucek K, Smarda J. Vanhara P, et al. Differentiation. 2009 Nov;78(4):213-22. doi: 10.1016/j.diff.2009.07.008. Epub 2009 Aug 19. Differentiation. 2009. PMID: 19695766

4

hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.

Wittinger M, Vanhara P, El-Gazzar A, Savarese-Brenner B, Pils D, Anees M, Grunt TW, Sibilia M, Holcmann M, Horvat R, Schemper M, Zeillinger R, Schöfer C, Dolznig H, Horak P, Krainer M. Wittinger M, et al. Among authors: vanhara p. Clin Cancer Res. 2011 Dec 15;17(24):7816-27. doi: 10.1158/1078-0432.CCR-11-0408. Epub 2011 Oct 20. Clin Cancer Res. 2011. PMID: 22016507

5

Growth/differentiation factor-15: prostate cancer suppressor or promoter?

Vaňhara P, Hampl A, Kozubík A, Souček K. Vaňhara P, et al. Prostate Cancer Prostatic Dis. 2012 Dec;15(4):320-8. doi: 10.1038/pcan.2012.6. Epub 2012 Feb 28. Prostate Cancer Prostatic Dis. 2012. PMID: 22370725 Review.

6

Methylation status of TUSC3 is a prognostic factor in ovarian cancer.

Pils D, Horak P, Vanhara P, Anees M, Petz M, Alfanz A, Gugerell A, Wittinger M, Gleiss A, Auner V, Tong D, Zeillinger R, Braicu EI, Sehouli J, Krainer M. Pils D, et al. Among authors: vanhara p. Cancer. 2013 Mar 1;119(5):946-54. doi: 10.1002/cncr.27850. Epub 2012 Oct 23. Cancer. 2013. PMID: 23096450 Free article.

7

Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.

Vaňhara P, Horak P, Pils D, Anees M, Petz M, Gregor W, Zeillinger R, Krainer M. Vaňhara P, et al. Int J Oncol. 2013 Apr;42(4):1383-9. doi: 10.3892/ijo.2013.1824. Epub 2013 Feb 12. Int J Oncol. 2013. PMID: 23404293

8

Mutual cytokine crosstalk between colon cancer cells and microenvironment initiates development of distant metastases.

Vaňhara P, Souček K. Vaňhara P, et al. JAKSTAT. 2013 Apr 1;2(2):e23810. doi: 10.4161/jkst.23810. JAKSTAT. 2013. PMID: 24058810 Free PMC article.

9

TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.

Horak P, Tomasich E, Vaňhara P, Kratochvílová K, Anees M, Marhold M, Lemberger CE, Gerschpacher M, Horvat R, Sibilia M, Pils D, Krainer M. Horak P, et al. Among authors: vanhara p. Sci Rep. 2014 Jan 17;4:3739. doi: 10.1038/srep03739. Sci Rep. 2014. PMID: 24435307 Free PMC article.

10

The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB.

Anees M, Horak P, Schiefer AI, Vaňhara P, El-Gazzar A, Perco P, Kiesewetter B, Müllauer L, Streubel B, Raderer M, Krainer M. Anees M, et al. Among authors: vanhara p. Leuk Lymphoma. 2015 May;56(5):1440-9. doi: 10.3109/10428194.2014.953149. Epub 2014 Nov 5. Leuk Lymphoma. 2015. PMID: 25248880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page